157 related articles for article (PubMed ID: 36439132)
1. Narrowband ultraviolet B response in cutaneous T-cell lymphoma is characterized by increased bacterial diversity and reduced
Hooper MJ; Enriquez GL; Veon FL; LeWitt TM; Sweeney D; Green SJ; Seed PC; Choi J; Guitart J; Burns MB; Zhou XA
Front Immunol; 2022; 13():1022093. PubMed ID: 36439132
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment.
Nguyen WQ; Chrisman LP; Enriquez GL; Hooper MJ; Griffin TL; Ahmad M; Rahman S; Green SJ; Seed PC; Guitart J; Burns MB; Zhou XA
Front Immunol; 2023; 14():1280205. PubMed ID: 38274799
[TBL] [Abstract][Full Text] [Related]
3. Gut dysbiosis in cutaneous T-cell lymphoma is characterized by shifts in relative abundances of specific bacterial taxa and decreased diversity in more advanced disease.
Hooper MJ; LeWitt TM; Pang Y; Veon FL; Chlipala GE; Feferman L; Green SJ; Sweeney D; Bagnowski KT; Burns MB; Seed PC; Choi J; Guitart J; Zhou XA
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1552-1563. PubMed ID: 35366365
[TBL] [Abstract][Full Text] [Related]
4. Nasal Dysbiosis in Cutaneous T-Cell Lymphoma Is Characterized by Shifts in Relative Abundances of Non-
Hooper MJ; LeWitt TM; Veon FL; Pang Y; Chlipala GE; Feferman L; Green SJ; Sweeney D; Bagnowski KT; Burns MB; Seed PC; Guitart J; Zhou XA
JID Innov; 2022 Sep; 2(5):100132. PubMed ID: 36161104
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal Communities on Skin Are Associated with Atopic Dermatitis and Disease Severity.
Edslev SM; Olesen CM; Nørreslet LB; Ingham AC; Iversen S; Lilje B; Clausen ML; Jensen JS; Stegger M; Agner T; Andersen PS
Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33669791
[TBL] [Abstract][Full Text] [Related]
6. Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies.
Kehrmann J; Koch F; Zumdick S; Höwner A; Best L; Masshöfer L; Scharfenberg S; Zeschnigk M; Becker JC; Schadendorf D; Buer J; Roesch A
Microbiol Spectr; 2023 Jun; 11(3):e0440122. PubMed ID: 37212689
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model.
Dey S; Vieyra-Garcia PA; Joshi AA; Trajanoski S; Wolf P
Front Immunol; 2024; 15():1255859. PubMed ID: 38646524
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T-cell lymphoma and Staphylococcus aureus colonization.
Nguyen V; Huggins RH; Lertsburapa T; Bauer K; Rademaker A; Gerami P; Guitart J
J Am Acad Dermatol; 2008 Dec; 59(6):949-52. PubMed ID: 18835065
[TBL] [Abstract][Full Text] [Related]
9. Significant Changes in the Skin Microbiome in Patients with Chronic Plaque Psoriasis after Treatment with Narrowband Ultraviolet B.
Assarsson M; Duvetorp A; Dienus O; Söderman J; Seifert O
Acta Derm Venereol; 2018 Apr; 98(4):428-436. PubMed ID: 29199351
[TBL] [Abstract][Full Text] [Related]
10. Changes in Lesional and Non-lesional Skin Microbiome During Treatment of Atopic Dermatitis.
Kwon S; Choi JY; Shin JW; Huh CH; Park KC; Du MH; Yoon S; Na JI
Acta Derm Venereol; 2019 Mar; 99(3):284-290. PubMed ID: 30460369
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients.
Emge DA; Bassett RL; Duvic M; Huen AO
Arch Dermatol Res; 2020 May; 312(4):283-288. PubMed ID: 31776647
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
13. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus.
Bjerre RD; Holm JB; Palleja A; Sølberg J; Skov L; Johansen JD
BMC Microbiol; 2021 Sep; 21(1):256. PubMed ID: 34551705
[TBL] [Abstract][Full Text] [Related]
14. Skin microbiome and its association with host cofactors in determining atopic dermatitis severity.
Rauer L; Reiger M; Bhattacharyya M; Brunner PM; Krueger JG; Guttman-Yassky E; Traidl-Hoffmann C; Neumann AU
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):772-782. PubMed ID: 36433676
[TBL] [Abstract][Full Text] [Related]
15. The impact of NBUVB on microbial community profiling in the lesional skin of vitiligo subjects.
Yuan X; Wang L; Meng D; Wu L; Wang X; Zhang D; Luo Z; Pang Y; Liu G
Microb Pathog; 2020 Mar; 140():103943. PubMed ID: 31917273
[TBL] [Abstract][Full Text] [Related]
16. Phototherapy for Cutaneous T-Cell Lymphoma.
Marka A; Carter JB
Dermatol Clin; 2020 Jan; 38(1):127-135. PubMed ID: 31753185
[TBL] [Abstract][Full Text] [Related]
17. Combining 16S Sequencing and qPCR Quantification Reveals
De Tomassi A; Reiter A; Reiger M; Rauer L; Rohayem R; Ck-Care Study Group ; Traidl-Hoffmann C; Neumann AU; Hülpüsch C
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509067
[TBL] [Abstract][Full Text] [Related]
18. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
[TBL] [Abstract][Full Text] [Related]
19. Case series of cutaneous T-cell lymphomas treated with bexarotene-based therapy.
Fujimura T; Sato Y; Tanita K; Amagai R; Shimauchi T; Ogata D; Fukushima S; Miyashita A; Fujisawa Y; Kambayashi Y; Aiba S
J Dermatol; 2020 Jun; 47(6):636-640. PubMed ID: 32207181
[TBL] [Abstract][Full Text] [Related]
20. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
Jo SJ; Kwon HH; Choi MR; Youn JI
Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
